Abstract
This article reviews and comments various laboratory tests that are commonly used in the investigation and assessment of environmental and occupational lung diseases affecting both the lung parenchyma per se as well as the airways and caused by exposure to various organic and inorganic materials. These conditions include asbestosis and silicosis, asthma, and hypersensitivity pneumonitis. The tests that are reviewed are (1) general lung function tests: lung volumes, CO diffusion, exercise testing; (2) specialized lung function tests: assessment of nonspecific bronchial responsiveness with methacholine and other agents, serial assessments of airway caliber with peak expiratory flows; specific inhalation tests; (3) assessment of airway inflammation by induced sputum and exhaled NO. The clinical indications and methodology of these tests are presented and discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pepys J, Jenkins P. Precipitin (F.L.H.) test in farmer’s lung. Thorax. 1965;20:21–35.
Bernstein I, Chan-Yeung M, Malo J, Berstein D. Asthma in the workplace. 3rd ed. New York, NY: Francis & Taylor; 2006.
Bernstein I, Chan-Yeung M, Malo J, Bernstein D. Definition and classification of asthma in the workplace. In: Chan-Yeung M, Malo JL, Bernstein DI, Bernstein IL, editors. Asthma in the workplace. 3rd ed. New York, NY: Francis & Taylor; 2006. p. 1–8.
Vandenplas O, Henneberger P. Socioeconomic outcomes in work-exacerbated asthma. Curr Opin Allergy Clin Immunol. 2007;7:236–41.
Blanc P, Toren K. Occupation in chronic obstructive pulmonary disease and chronic bronchitis: an update. Int J Tuberc Lung Dis. 2007;11:251–7.
Society AT. Guidelines for methacholine and exercise challenge testing. Am J Respir Crit Care Med. 2000;161:309–29.
Ryan G, Latimer K, Dolovich J, Hargreave F. Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax. 1982;37:423–9.
Dautrebande L, Philippot E. Crise d’asthme expérimental par aérosols de carbaminoylcholine chez l’homme traitée par dispersat de phénylaminopropane. Presse Med. 1941;49:942–6.
Tiffeneau R, Beauvallet M. Épreuve de bronchoconstriction et de bronchodilatation par aérosols. Emploi pour le dépistage, la mesure et le contrôle des insuffisances respiratoires chroniques. Bull Acad Natl Med. 1945;129:165–8.
Curry J. The action of histamine on the respiratory tract in normal and asthmatic subjects. J Clin Invest. 1946;25:785–91.
Chai H, Farr R, Froehlich L, Mathison D, McLean J, Rosenthal R, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol. 1975;56:323–7.
Cockcroft D, Killian D, Mellon J, Hargreave F. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977;7:235–43.
Bateman E, Hurd S, Barnes P, Bousquet J, Drazen J, FitzGerald M, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31:143–78.
Adelroth E, Hargreave F, Ramsdale E. Do physicians need objective measurements to diagnose asthma? Am Rev Respir Dis. 1986;134:704–7.
Ringsberg K, Akerlind I. Presence of hyperventilation in patients with asthma-like symptoms but negative asthma test responses: provocation with voluntary hyperventilation and mental stress. J Allergy Clin Immunol. 1999;103:601–8.
Anderson S. Provocative challenges to help diagnose and monitor asthma: exercise, methacholine, adenosine, and mannitol. Curr Opin Pulm Med. 2008;14:39–45.
McFadden E, Ingram R. Exercise-induced asthma. N Engl J Med. 1979;301:763–9.
Eggleston P, Rosenthal R, Anderson S, Anderton R, Bierman C, Bleecker E, et al. Guidelines for the methodology of exercise challenge testing of asthmatics. J Allergy Clin Immunol. 1979;64:642–5.
Desjardins A, Luca S, Cartier A, L’Archevêque J, Ghezzo H, Malo J-L. Nonspecific bronchial hyperresponsiveness to inhaled histamine and hyperventilation of cold dry air in subjects with respiratory symptoms of uncertain etiology. Am Rev Respir Dis. 1988;137:1020–5.
Cockcroft D, Davis B. Direct and indirect challenges in the clinical assessment of asthma. Ann Allergy Asthma Immunol. 2009;103:363–9.
Troyanov S, Malo J, Cartier A, Gautrin D. Frequency and determinants of exaggerated bronchoconstriction during shortened methacholine challenge tests in epidemiological and clinical set-ups. Eur Respir J. 2000;16:9–14.
Perpina M, Pellicer C, Diego A, Compte L, Macian V. Diagnostic value of the bronchial provocation test with methacholine in asthma. A Bayesian analysis approach. Chest. 1993;104:149–54.
Lévesque M, Ghezzo H, L’archevêque J, Malo J. Does the methacholine test reproduce symptoms? Can Respir J. 2010;17:224–8.
Boulet L-P, Cartier A, Thomson N, Roberts R, Dolovich J, Hargreave F. Asthma and increases in nonallergic bronchial responsiveness from seasonal pollen exposure. J Allergy Clin Immunol. 1983;71:399–406.
Cartier A, Malo J-L, Forest F, Lafrance M, Pineau L, St-Aubin J-J, et al. Occupational asthma in snow crab-processing workers. J Allergy Clin Immunol. 1984;74:261–9.
Malo J, Ghezzo H, L’Archevêque J, Cartier A. Late asthmatic reactions to occupational sensitizing agents: frequency of changes in nonspecific bronchial responsiveness and of response to inhaled beta-2 adrenergic agent. J Allergy Clin Immunol. 1990;85:834–42.
Sastre J, Fernandez-Nieto M, Novalbos A, Heras MDL, Cuesta J, Quirce S. Need for monitoring nonspecific bronchial hyperresponsiveness before and after isocyanate inhalation challenge. Chest. 2003;123:1276–9.
Vandenplas O, Delwiche J, Jamart J, Weyer RVD. Increase in non-specific bronchial hyperresponsiveness as an early marker of bronchial response to occupational agents during specific inhalation challenges. Thorax. 1996;51:472–8.
Nam Y, Kim J, Um S, Lee S, Son C. Absence of hyper-responsiveness to methacholine after specific bronchial provocation tests in a worker with hydroxyapatite-induced occupational asthma. Allergy Asthma Immunol Res. 2011;3:135–7.
Tiffeneau R. Hypersensibilité cholinergo-histaminique pulmonaire de l’asthmatique; relation avec l’hypersensibilité allergénique pulmonaire. Acta Allergol Suppl (Copenh). 1958;5:187–221.
Cockcroft D, Ruffin R, Frith P, Cartier A, Juniper E, Dolovich J, et al. Determinants of allergen-induced asthma: dose of allergen, circulating IgE antibody concentration, and bronchial responsiveness to inhaled histamine. Am Rev Respir Dis. 1979;120:1053–8.
Cockcroft D, Murdock K, Kirby J, Hargreave F. Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. Am Rev Respir Dis. 1987;135:264–7.
Quirce S, Fernández-Nieto M, Escudero C, Cuesta J, de Las Heras M, Sastre J. Bronchial responsiveness to bakery-derived allergens is strongly dependent on specific skin sensitivity. Allergy. 2006;61(10):1202–8.
Malo J, Cardinal S, Ghezzo H, L’archevêque J, Castellanos L, Maghni K. Association of bronchial reactivity to occupational agents with methacholine reactivity, sputum cells and immunoglobulin E-mediated reactivity. Clin Exp Allergy. 2011;41:497–504.
Bousquet J, Chanez P, Lacoste J-Y, Barnéon G, Ghavanian N, Enander I, et al. Eosinophilic inflammation in asthma. N Eng J Med. 1990;323:1033–9.
Sumi Y, Foley S, Daigle S, L’archeveque J, Olivenstein R, Letuve S, et al. Structural changes and airway remodelling in occupational asthma at a mean interval of 14 years after cessation of exposure. Clin Exp Allergy. 2007;37:1781–7.
Bahous J, Cartier A, Ouimet G, Pineau L, Malo J-L. Nonallergic bronchial hyperexcitability in chronic bronchitis. Am Rev Respir Dis. 1984;129:216–20.
Society AT. Guidelines for the evaluation of impairment/disability in patients with asthma. Am Rev Respir Dis. 1993;147:1056–61.
Cocchiarella L, Andersson GBJ, editors. Guides to the evaluation of permanent impairment. 5th ed. Chicago, IL: AMA; 2001. p. 102–4.
Epstein S, Fletcher C, Oppenheimer E. Daily peak flow measurements in the assessment of steroid therapy for airway obstruction. Br Med J. 1969;1:223–5.
Turner-Warwick M. On observing patterns of airflow obstruction in chronic asthma. Br J Dis Chest. 1977;71:73–86.
Clark T, Hetzel M. Diurnal variation of asthma. Br J Dis Chest. 1977;71:87–92.
Verschelden P, Cartier A, L’Archevêque J, Trudeau C, Malo J. Compliance with and accuracy of daily self-assessment of peak expiratory flows (PEF) in asthmatic subjects over a three month period. Eur Respir J. 1996;9:880–5.
Burge P, O’Brien I, Harries M. Peak flow rate records in the diagnosis of occupational asthma due to colophony. Thorax. 1979;34:308–16.
Burge P, O’Brien I, Harries M. Peak flow rate records in the diagnosis of occupational asthma due to isocyanates. Thorax. 1979;34:317–23.
Burge P. Diagnosis of occupational asthma. Clin Allergy. 1989;19:649–52.
Gannon P, Newton D, Belcher J, Pantin C, Burge P. Development of OASYS-2: a system for the analysis of serial measurement of peak expiratory flow in workers with suspected occupational asthma. Thorax. 1996;51:484–9.
Malo J, Cartier A, Ghezzo H, Chan-Yeung M. Compliance with peak expiratory flow readings affects the within- and between- reader reproducibility of interpretation of graphs in subjects investigated for occupational asthma. J Allergy Clin Immunol. 1996;98:1132–4.
Blackley C. Experimental researches on the causes and nature of Catarrhus aestivus. London: Dawson’s of Pall Mall; 1959. p. 80–1.
Colldahl H. A study of provocation test on patients with bronchial asthma. Acta Allergol. 1952;5:133–42.
Pepys J, Hutchcroft B. Bronchial provocation tests in etiologic diagnosis and analysis of asthma. Am Rev Respir Dis. 1975;112:829–59.
Chan-Yeung M, Malo J. Occupational asthma. N Engl J Med. 1995;333:107–12.
Vandenplas O, Malo J. Inhalation challenges with agents causing occupational asthma. Eur Respir J. 1997;10:2612–29.
Vandenplas O, Cartier A, Malo J. Occupational challenge tests. In: Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI, editors. Asthma in the workplace. 3rd ed. New York: Taylor & Francis; 2006. p. 227–52.
Caron S, Boileau J, Malo J, Leblond S. New methodology for specific inhalation challenges with occupational agents. Respir Res. 2010;11:72.
Gibson P, Dolovich J, Denburg J, Ramsdale E. Chronic cough: Eosinophilic bronchitis without asthma. Lancet. 1989;1(8651):1346–8.
Quirce S. Eosinophilic bronchitis in the workplace. Curr Opin Allergy Clin Immunol. 2004;4:87–91.
Berry M, Hargadon B, McKenna S, Shaw D, Green R, Brightling C, et al. Observational study of the natural history of eosinophilic bronchitis. Clin Exp Allergy. 2005;35:598–601.
Takeda N, Maghni K, Daigle S, L’Archevêque J, Castellanos L, Al-Ramli W, et al. Long-term pathologic consequences of acute irritant-induced asthma. J Allergy Clin Immunol. 2009;124:975–81.
Herxheimer H. The late bronchial reaction in induced asthma. Int Arch Allergy Appl Immunol. 1952;3:323–8.
Pepys J. Inhalation challenge tests in asthma. New Engl J Med. 1975;293:758–9.
Orange R, Austen G, Austen K. Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. J Exp Med. 1971;134:136s–48.
Editorial. Slow-reacting substance of anaphylaxis—leukotrienes. Lancet. 1980;2:1226–7.
Amin K, Ludviksdottir D, Janson C, Nettelbladt O, Bjornsson E, Roomans G, et al. Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. Am J Respir Crit Care Med. 2000;162:2295–301.
Brown HM. Treatment of chronic asthma with prednisolone. Significance of eosinophils in the sputum. Lancet. 1958;2:1245–7.
Pin I, Gibson P, Kolendowicz F, Girgis-Gabardo A, Denburg J, Hargreave F, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax. 1992;47:25–9.
Fahy J, Liu J, Wong H, Boushey H. Analysis of cellular and biochemical constituents of induced sputum after allergen challenge: A method for studying allergic airway inflammation. J Allergy Clin Immunol. 1994;93:1031–9.
Deykin A, Lazaru S, Fahy J, Wechsler M, Boushey H, Chinchilli V, et al. Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. J Allergy Clin Immunol. 2005;115:720–7.
Belda J, Parameswaran K, Lemière C, Kamada D, O’Byrne P, Hargreave F. Predictors of loss of asthma control induced by corticosteroid withdrawal. Can Respir J. 2006;13:129–33.
Girard F, Chaboillez S, Cartier A, Côté J, Hargreave F, Labrecque M, et al. An effective strategy for diagnosing occupational asthma. Induced sputum. Am J Respir Crit Care Med. 2004;170:845–50.
Dehaut P, Rachiele A, Martin R, Malo J. Histamine dose-response curves in asthma: reproducibility and sensitivity of different indices to assess response. Thorax. 1983;38:516–22.
Boschetto P, Mapp C, Picotti G, Fabbri L. Neutrophils and asthma. Eur Respir J. 1989;2(Suppl):456s–9.
Lemière C, Romeo P, Chaboillez S, Tremblay C, Malo J. Airway inflammation and functional changes after exposure to different concentrations of isocyanates. J Allergy Clin Immunol. 2002;110:641–6.
Maghni K, Lemière C, Ghezzo H, Yuquan W, Malo J. Airway inflammation after cessation of exposure to agents causing occupational asthma. Am J Respir Crit Care Med. 2004;169:367–72.
Malo J, L’archevêque J, Castellanos L, Lavoie K, Ghezzo H, Maghni K. Long-term outcomes of acute irritant-induced asthma. Am J Respir Crit Care Med. 2009;179:923–8.
Maghni K, Malo J, L’Archevêque J, Castellanos L, Gautrin D. Matrix metalloproteinases, IL-8 and glutathione in the prognosis of workers exposed to chlorine. Allergy. 2010;65:722–30.
Corradi M, Gergelova P, Mutti A. Use of exhaled breath condensate to investigate occupational lung diseases. Curr Opin Allergy Clin Immunol. 2010;10:93–8.
Society AT. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171:912–30.
Dweik R, Boggs P, Erzurum S, Irvin C, Leigh M, Lundberg J, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184:602–15.
Ihre E, Gyllfors P, Gustafsson L, Kumlin M, Dahlén B. Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge. Eur Respir J. 2006;27:1152–9.
Lemière C, D’Alpaos V, Chaboillez S, César M, Wattiez M, Chiry S, et al. Investigation of Occupational Asthma: Sputum Cell Counts or Exhaled Nitric Oxide? Chest. 2010;137:617–22.
Smith A, Cowan J, Brassett K, Herbison G, Taylor D. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med. 2005;352:2163–73.
Cocker J. Biological monitoring for isocyanates. Ann Occup Hyg. 2011;68:176–82.
Acknowledgement
The author sincerely thanks Kathe Lieber for reviewing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this chapter
Cite this chapter
Malo, JL. (2012). Use of Laboratory Tests in Occupational and Environmental Lung Diseases. In: Huang, YC., Ghio, A., Maier, L. (eds) A Clinical Guide to Occupational and Environmental Lung Diseases. Respiratory Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-149-3_3
Download citation
DOI: https://doi.org/10.1007/978-1-62703-149-3_3
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-148-6
Online ISBN: 978-1-62703-149-3
eBook Packages: MedicineMedicine (R0)